BIVI

 
Common Stock SEC Reporting - Current
OTC Pink Current Information
Contact Info
  • 100 Cummings Center
  • Suite 247-C
  • Beverly, MA 01915

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001580149
Fiscal Year End 6/30
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2013
Employees Not Available
Company Officers/Contacts
Jonathan Adams CEO
Amrit Shahzah President
Company Directors
Jonathan Adams
Cuong Do
Amrit Shahzah
Company Notes
  • Formerly=NanoAntibiotics, Inc. until 8-2016
Service Providers
Accounting/Auditing Firm
Weinberg & Baer LLC
115 Sudbrook Lane
Baltimore, MD, 21208
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available
BIVI Security Details
Share Structure
Market Value1 $19,186,200 a/o Dec 01, 2016
Authorized Shares 300,000,000 a/o Sep 30, 2013
Outstanding Shares 87,210,000 a/o Sep 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.001
Transfer Agent(s)
West Coast Stock Transfer Inc.
Shareholders
Shareholders of Record 87 a/o Sep 28, 2016
Short Selling Data
Short Interest 1,530 (5,000%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security